Literature DB >> 32087802

Approval of esketamine for treatment-resistant depression - Authors' reply.

Florian Naudet1, Ioana A Cristea2.   

Abstract

Entities:  

Year:  2020        PMID： 32087802     DOI： 10.1016/S2215-0366(20)30040-7

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  3 in total

Review 1.  Orphan G Protein Coupled Receptors in Affective Disorders.

Authors:  Lyndsay R Watkins; Cesare Orlandi
Journal:  Genes (Basel)       Date:  2020-06-24       Impact factor: 4.096

2.  Esketamine clinical trials: reply to Maju et al.

Authors:  C Gastaldon; D Papola; G Ostuzzi; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2020-04-29       Impact factor: 6.892

3.  The evidence base for psychotropic drugs approved by the European Medicines Agency: a meta-assessment of all European Public Assessment Reports.

Authors:  Florian Erhel; Alexandre Scanff; Florian Naudet
Journal:  Epidemiol Psychiatr Sci       Date:  2020-04-27       Impact factor: 6.892
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.